VINCERX PHARMA INC. -
0.5917
24-6月-24 15:59:57
15 分の遅延
株式
-0.0083
-1.38%
本日の幅
0.5684 - 0.6150
ISIN
N/A
ソース
NASDAQ
-
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
14 5 2024 16:15:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
26 4 2024 00:27:06 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
25 4 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
29 3 2024 15:20:52 提供 Nasdaq GlobeNewswire
-
05 3 2024 16:31:00 提供 Nasdaq GlobeNewswire
-
07 1 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
10 12 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
14 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma To Present Three Posters at ASH 2023 in December
02 11 2023 09:10:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
19 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943
14 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Announces FDA Clearance of IND for VIP943
22 8 2023 07:30:09 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
07 8 2023 09:25:00 提供 Nasdaq GlobeNewswire
-
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
11 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
17 4 2023 13:35:00 提供 Nasdaq GlobeNewswire
-
28 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >